Meeting Banner
Abstract #0153

A Novel MR-Visible Persistent Apoptosis Marker Validated with Immunohistochemistry

Firas Moosvi1, Jennifer H.E. Baker, 12, Andrew Yung1, Kenneth Curry3, Stefan A. Reinsberg1

1Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada; 2Radiation Biology, BC Cancer Research Institute, Vancouver, BC, Canada; 3RF Therapeutics, Vancouver, BC, Canada

We validate an MR-visible, necrosis-avid contrast agent(RF1101) using TUNEL staining and DCEMRI. The agent is injected and binds to areas of apoptosis/necrosis and unbound agent is excreted from the systemic circulation. T1-weighted imaging is performed after approximately 24h to identify areas of contrast agent uptake. Data from a preclinical cancer model is shown with spectacular agreement between histologically identified areas of necrosis and RF1106 uptake.

Keywords

action administered administration aims allowed animals another arrow assess astronomy audience baker bind binding binds biology blood blue bound built camera cancer carcinoma cell cells central circulation cleared clinical coil compound confirmed contrast core correlate correlates correlation course currently curry custom differentiating diluted distribution dose dynamic either enhance enhanced enhancement every excised exploited facilitate feasibility fiducial flank frozen fully furthermore gadolinium goal gradient heterogeneity heterogeneous highly histology hours identified immediately implanted incubation indicate indicates injected injection institute intensities intermediate international intravenously inversion manually mark marked marker mechanisms metabolizing mice microscope models necrosis necrotic need novel nuclei oncology optimization path persistent persists physics pilot plots poorly prior protocol radiation rare reached receive recovery remarkably resolution saline section sections shortened shortening slice slices spatial spoiled stages stained staining strong studies surface systemic target temporal therapeutics thick think tiled tissue transmit tube unbound underway utility validated validation vascular vessel vessels visible white whole wise